We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RTSL market cap is 8.83k. The company's latest EPS is USD 0.0034 and P/E is 0.00.
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9k | 131k | 1,000 | 0 | 0 |
| Operating Income | -433k | -1.99M | -2.17M | -1.26M | -306k |
| Net Income | -625k | -2.05M | -2.87M | -1.8M | 30k |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 445k | 1.51M | 2.2M | 2.26M | 1.94M |
| Total Liabilities | 1.81M | 1.52M | 3.58M | 5.4M | 4.84M |
| Total Equity | -1.36M | -11k | -1.38M | -3.14M | -2.9M |
| Year End 31 December 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -191k | -1.73M | -2.21M | -1.15M | -31k |
| Investing | -155k | -107k | -293k | -39k | N/A |
| Financing | 481k | 2.2M | 2.2M | 999k | 41k |
| Market Cap | 8.83k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 8.83M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 5.09k |
| 52 Week Change | -81.82% |
| 52 Week High | 0.006 |
| 52 Week Low | 0.0005 |
| Spread (Intraday) | 0 (75%) |
| Company Name | Rapid Therapeutic Science Laboratories Inc (PK) |
| Address |
112 north curry street carson city, nevada 89703 |
| Website | https://www.rtslco.com |
| Industry | computer related svcs, nec (7379) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
